Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:386451.
doi: 10.1155/2015/386451. Epub 2015 Oct 15.

The Iron Status of Sickle Cell Anaemia Patients in Ilorin, North Central Nigeria

Affiliations

The Iron Status of Sickle Cell Anaemia Patients in Ilorin, North Central Nigeria

Musa A Sani et al. Adv Hematol. 2015.

Abstract

Objectives. Sickle cell anaemia (SCA) is one of the commonest genetic disorders in the world. It is characterized by anaemia, periodic attacks of thrombotic pain, and chronic systemic organ damage. Recent studies have suggested that individuals with SCA especially from developing countries are more likely to be iron deficient rather than have iron overload. The study aims to determine the iron status of SCA patients in Ilorin, Nigeria. Methods. A cross-sectional study of 45 SCA patients in steady state and 45 non-SCA controls was undertaken. FBC, blood film, sFC, sTfR, and sTfR/log sFC index were done on all subjects. Results. The mean patients' serum ferritin (589.33 ± 427.61 ng/mL) was significantly higher than the mean serum ferritin of the controls (184.53 ± 119.74 ng/mL). The mean serum transferrin receptor of the patients (4.24 ± 0.17 μg/mL) was higher than that of the controls (3.96 ± 0.17 μg/mL) (p = 0.290). The mean serum transferrin receptor (sTfR)/log serum ferritin index of the patients (1.65 ± 0.27 μg/mL) was significantly lower than that of the control (1.82 ± 0.18 μg/mL) (p = 0.031). Conclusion. Iron deficiency is uncommon in SCA patients and periodic monitoring of the haematological, biochemical, and clinical features for iron status in SCA patients is advised.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Halim N. K. D., Famodu A. A., Wemambu S. N. C. Textbook of Clinical Haematology and Immunology. 2nd. Ambik; 2001.
    1. Nnaji G. A., Ezeagwuna D. A., Nnaji I. J. F., Osakwe J. O., Nwigwe A. C., Onwurah O. W. Prevalence and pattern of sickle cell disease in premarital couples in Southeastern Nigeria. Nigerian Journal of Clinical Practice. 2013;16(3):309–314. doi: 10.4103/1119-3077.113452. - DOI - PubMed
    1. Lai A., Vinchisky E. P. Sickle cell disease. In: Hoffbrand A. V., Daniel C., Tuddenham E. G. D., editors. Postgraduate Haematology. 5th. Malden, Mass, USA: Blackwell; 2005. pp. 104–118.
    1. O'Brien R. T. Iron burden in sickle cell anemia. The Journal of Pediatrics. 1978;92(4):579–582. doi: 10.1016/S0022-3476(78)80291-1. - DOI - PubMed
    1. Cohen A., Schwartz E. Excretion of iron in response to deferoxamine in sickle cell anemia. The Journal of Pediatrics. 1978;92(4):659–662. doi: 10.1016/S0022-3476(78)80317-5. - DOI - PubMed

LinkOut - more resources